ARTICLE | Finance
Ready to ramp
Why Dell Technologies Capital led Edico Genome’s $22 million series B round
May 13, 2017 1:50 AM UTC
A day after emerging from stealth mode, strategic investor Dell Technologies Capital backed Edico Genome Inc. to ramp up the launch of a bioinformatics processor used to analyze sequencing data.
The VC led Edico’s $22 million series B round announced May 9. All existing investors participated, including Qualcomm Ventures, Axon Ventures and board member Greg Lucier...
BCIQ Company Profiles